These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 28382493

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.
    Hedenmalm K, Samuelsson E.
    Drug Saf; 2005; 28(10):907-16. PubMed ID: 16180940
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease.
    Jick S, Pennap D.
    Contraception; 2012 Sep; 86(3):220-3. PubMed ID: 22325114
    [Abstract] [Full Text] [Related]

  • 45. Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.
    Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J.
    Front Endocrinol (Lausanne); 2021 Sep; 12():769187. PubMed ID: 34956081
    [Abstract] [Full Text] [Related]

  • 46. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
    Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F, Leydon GM.
    Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
    [Abstract] [Full Text] [Related]

  • 47. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
    Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C.
    BMJ; 2009 Aug 13; 339():b2890. PubMed ID: 19679613
    [Abstract] [Full Text] [Related]

  • 48. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
    Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP, Cooper WO.
    Contraception; 2013 Jan 13; 87(1):93-100. PubMed ID: 23083525
    [Abstract] [Full Text] [Related]

  • 49. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice.
    Obstet Gynecol; 2012 Nov 13; 120(5):1239-42. PubMed ID: 23090561
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG, Burke AE, Espey E.
    Obstet Gynecol; 2012 May 13; 119(5):1039-44. PubMed ID: 22525916
    [Abstract] [Full Text] [Related]

  • 53. Drospirenone and VTE.
    Leppée M, Eric M, Culig J.
    J Fam Plann Reprod Health Care; 2010 Jan 13; 36(1):44. PubMed ID: 20067674
    [No Abstract] [Full Text] [Related]

  • 54. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V, Milsom I, Persson I, Victor A.
    Acta Obstet Gynecol Scand; 2002 Jun 13; 81(6):482-90. PubMed ID: 12047300
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
    Kaplan S, Bertoia ML, Wang FT, Zhou L, Lass A, Evans A, Dhanda S, Roy D, Seeger JD.
    Contraception; 2022 Jan 13; 105():26-32. PubMed ID: 34599911
    [Abstract] [Full Text] [Related]

  • 57. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R, CLINICAL PRACTICE GYNAECOLOGY COMMITTEE.
    J Obstet Gynaecol Can; 2010 Dec 13; 32(12):1192-1197. PubMed ID: 21176332
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
    Gronich N, Lavi I, Rennert G.
    CMAJ; 2011 Dec 13; 183(18):E1319-25. PubMed ID: 22065352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.